US pharma firm, Advanced Penetration Technology tests FDA-approved ointment to treat COVID-19.

- August 24, 2020

Exploration infers that APT T3X adequately kills viral infectivity in no time and its effective intranasal use can diminish the viral heap of presentation.

Washington: A US pharma organization has effectively tried a Food and Drug Administration-endorsed over the counter (OTC) ointment as the primary line of guard against the destructive coronavirus. Scientists related to this project said the FDA-enrolled non-solution OTC ointment for treating and helps to destroy viral diseases including COVID.

According to the latest study from Massachusetts Institutes of Technology (MIT) states that people who have tested positive for COVID-19 or other viruses, primarily infected through the nose. Still, apart from that mouth, the eye may also responsible for the entry of the virus inside the body.

“FDA officially announced T3X, as over-the-counter formulation, means no doctor’s written prescription is required to use this. It’s so handy to use its self-administered medication no medical expert or no expert supervision needed” the company said.

ATP T3X is evaluated and confirmed that the product, named as APT T3X, by London Based research laboratory, Virology Research Services. And this laboratory confirmed that ATP T3X is highly effective against Coronavirus(NL63) and Influenza A virus.; The research study states that APT T3X very effectively and efficiently tackle and destroy viral infectivity within seconds. Topical intranasal use of ATP T3X will definitely decrease the viral load.

According to the Massachusetts Institute of Technology (MIT) study; “Under clinical trial conditions APT T3X resulted in 99.9% virucidal activity against dangerous Coronavirus NL63.” The testing was performed for more than two months, in May and June.

This antiviral product developed eight years ago to control and treat viral infections as an antiviral agent, additionally, it shows actions over fungal diseases also. It has no officially disclosed side effects.

How Coronavirus enters the body?

Scientists over the world doing continuous research to understand how to Corona spreads and how it affects the people, out of them some scientist are saying that two specifics cells present in the human nose that is responsible for entering the coronavirus in the body.by the report of The Indian Express, they states that two cells i.e. goblet cells and ciliated cells this two types of cells where entry mechanism of SARS-CoV2 takes place & virus starts to attack.

This study regarding coronavirus has been disclosed by scientists in University Medical Centre Groningen, Wellcome Sanger Institute (UK), Goblet cells are those cells which produce mucus in the nose and respiratory tract. Hair like structured ciliated cells that helps to sweep mucus or dust to the throat. Similar types of proteins are also present in the cornea site in the eyes and epithelial linings of the intestine.therefor for viruses, the cornea will become another route to enter the body. In some cases, viruses get entered through via tear duct also.

How did researchers identify the nasal cavity as an initial entry point for the virus?

Researchers looked for all the organs containing protein ACE2 and TMPRSS2 prominently, by looking at many tissues of noninfected people, the report added, it was found that cells from the lung, nasal cavity, heart, kidney, gut, liver have present proteins. After that, it was identified that ciliated cells and goblet cells have produced a comparatively maximum amount of these proteins. Therefore it acted as an active route for the COVID-19 virus to enter the body. The nasal cavity is an easily findable route for the viruses, rather than other entry points.

Similar types of proteins are also present in the cornea site in the eyes and epithelial linings of the intestine.therefor for viruses, the cornea will become another route to enter the body. In some cases, viruses get entered through via tear duct also.